Skip to main content

Table 2 Distribution of the IC50 values and their respective confidence intervals (95%) in MCF-7, 4T1, and MCF-10A cell lines after treatment with free rhodium (II) citrate (Rh2(H2cit)4).

From: Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy

 

IC50 (IC 95%)

Cell lines

24 hours

48 hours

72 hours

MCF-7

483 μM

(459,2 a 507 μM)

376 μM

(356,2 a 396,1 μM)

294 μM

(259,9 a 332,5 μM)

4T1

440 μM

(407,3 a 475 μM)

337 μM

(317,3 a 357,8 μM)

271 μM

(241,4 a 303,9 μM)

MCF-10A

250 μM

(211,1 a 295,2 μM)

181 μM

(172,3 a 190,8 μM)

123 μM

(114,7 a 132,7 μM)

  1. These data refers from viability of cells after treatment with Rh2(H2cit)4 (50-600 μM) for 24, 48 and 72 hours.